Precision BioSciences, Inc. (DTIL) vs PepGen, Inc. (PEPG)

Precision BioSciences, Inc. and PepGen, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and PepGen, Inc. are of similar size ($175.2M and $170.3M). Across the 11 metrics below, PepGen, Inc. leads on 6 and Precision BioSciences, Inc. on 5.

Valuation

Metric DTIL PEPG Biotechnology median
P/E n/m n/m 8.50
P/S 3.31 n/m 9.71
P/B 3.29 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.87 n/m 9.21
Earnings yield (48.35%) (50.38%) (33.15%)
Free cash flow yield (35.07%) (38.63%) (25.50%)

Profitability

Metric DTIL PEPG Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (132.91%) (75.45%) (56.36%)
Return on assets (44.91%) (59.06%) (48.04%)
Return on invested capital 0.00% (2,076.25%) 0.00%

Growth

Metric DTIL PEPG Biotechnology median
Revenue growth (TTM) (11.87%) — 6.02%
EPS growth (last fiscal year) (442.31%) 25.61% 30.26%
Revenue growth, 5-year CAGR 7.13% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL PEPG Biotechnology median
Debt to equity 0.50 0.00 0.00
Current ratio 12.82 13.36 4.72
Net debt to EBITDA 1.86 1.64 0.96

Dividend

Metric DTIL PEPG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DTIL PEPG Biotechnology median
Market cap 170.30m 175.22m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack